EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Molecular Docking Of Bioactive Compounds From Mangosteen Peel (Garcinia Mangostana L.) And Design Of New Quercetin Derivatives As MAO-A Inhibitors For Anti-Stress Potential

Syafi’Atul ‘Aliyah, Tatiana Siska Wardani, Siwi Hastuti, Tiara Ajeng Listyani

International Journal of Health Engineering and Technology · 03.11.2026 · 5 (4)

DOI: 10.55227/ijhet.v5i3.1236 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Health Engineering and Technology, online erschienen am 03.11.2026. Verfasst von Syafi’Atul ‘Aliyah und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Stress is associated with an imbalance of neurotransmitters in the central nervous system. Monoamine Oxidase A (MAO-A) plays a role in the metabolism of monoamine neurotransmitters and therefore, has potential as a target for the development of anti-stress agents. Mangosteen peel (Garcinia mangostana L.) contains various bioactive compounds with potential for development as anti-stress agent candidates. This study aimed to analyze the interactions of bioactive compounds from mangosteen peel with MAO-A through molecular docking and to evaluate drug-likeness, ADME, toxicity, and structural modification of the selected compound. An in silico study was conducted on 70 bioactive compounds using PyRx-AutoDock Vina with MAO-A (PDB ID: 2Z5X). Validation was performed by redocking the native ligand Harmine. The selected compounds were subsequently analyzed using SwissADME, pkCSM, and Toxtree. Redocking of Harmine produced an RMSD of 1.581 Å and a binding affinity of −8.2 kcal/mol, indicating that the method was valid. The four best-performing compounds were Quercetin, Apigenin, Smeathxanthone A, and Epicatechin, with binding affinity of −9.0, −8.9, −8.6, and −7.4 kcal/mol, respectively. Quercetin was selected based on its lowest binding affinity and similarity of amino acid residue interactions with the native ligand. Modification of Quercetin produced (Z)-4-(prop-1-en-1-yl)-3,6-dihydro-[1,1'-biphenyl]-2,3',4'-triol with a binding affinity of −8.7 kcal/mol and an RMSD of 1.321 Å, accompanied by an improved ADME profile and low toxicity. The modified compound has potential for further development as an anti-stress agent candidate targeting MAO-A, however, further in vitro and in vivo studies are required.

Zitieren

APA

‘Aliyah, S., Wardani, T. S., Hastuti, S., & Listyani, T. A. (2026). Molecular Docking Of Bioactive Compounds From Mangosteen Peel (Garcinia Mangostana L.) And Design Of New Quercetin Derivatives As MAO-A Inhibitors For Anti-Stress Potential. International Journal of Health Engineering and Technology, 5(4). https://doi.org/10.55227/ijhet.v5i3.1236

Vancouver

‘Aliyah S, Wardani TS, Hastuti S, Listyani TA. Molecular Docking Of Bioactive Compounds From Mangosteen Peel (Garcinia Mangostana L.) And Design Of New Quercetin Derivatives As MAO-A Inhibitors For Anti-Stress Potential. International Journal of Health Engineering and Technology. 2026;5(4). doi:10.55227/ijhet.v5i3.1236

BibTeX
@article{Aliyah2026,
  author = {‘Aliyah, Syafi’Atul and Wardani, Tatiana Siska and Hastuti, Siwi and Listyani, Tiara Ajeng},
  title = {Molecular Docking Of Bioactive Compounds From Mangosteen Peel (Garcinia Mangostana L.) And Design Of New Quercetin Derivatives As MAO-A Inhibitors For Anti-Stress Potential},
  journal = {International Journal of Health Engineering and Technology},
  year = {2026},
  volume = {5},
  number = {4},
  doi = {10.55227/ijhet.v5i3.1236}
}
Kostenlos starten →